ADDvise Group AB (publ) to redeem its outstanding up to SEK 240,000,000 senior secured callable bonds with ISIN SE0010298166

16-06-2021   Regulatory press release

We refer to the outstanding up to SEK 240,000,000 senior secured callable bonds issued by ADDvise Group AB (publ) (the "Company") with ISIN: SE0010298166 (the "Bonds") and to the terms and conditions of the Bonds (the "Terms and Conditions").

Reference is further made to a call notice dated 21 May 2021, in which the Company informed the holders of the Bonds that it exercises its option to redeem all outstanding Bonds in full pursuant to Clause 8.3 (Voluntary total redemption (call option)) of the Terms and Conditions (the "Call Notice"), on 18 June 2021 (the "Redemption Date"). The Company's obligation to redeem the Bonds on the Redemption Date is conditioned upon the Company issuing senior secured floating rate bonds on terms that are acceptable for the Company (the "New Bonds") and fulfilling the conditions precedent for disbursement of the net proceeds from the issue of the New Bonds which are, among other things, to be applied towards financing the redemption of the Bonds (the "Financing Condition").

The Company hereby confirms that the Financing Condition will be fulfilled and will redeem the outstanding Bonds on the Redemption Date in accordance with the Call Notice.
 

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71

rikard.akhtarzand@addvisegroup.se

 

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.

Latest press releases

ADDvise announces preliminary result for 2022 which is stronger than expected

Regulatory

The preliminary result for ADDvise Group for the full year 2022 significantly deviates from what ADDvise Group considers to be current market expectations. [image] The net sales pro forma full year 2022 rolling 12 months amounted to SEK 1,097 million with an adjusted EBITDA pro forma of SEK 241 million. The financial targets for the…

ADDvise receives order worth USD 3.5 million

Regulatory

ADDvise Group AB’s subsidiary Poly Pharmaceuticals Inc has received an order from AxisCare Health Logistics Inc, a company distributing equipment and medical supplies to hospitals, clinics, medical offices and medical equipment suppliers. The order is worth approximately USD 3.5 million. The order consists of delivery of the prescription dietary supplemental Folite, developed and manufactured by…

ADDvise receives order worth USD 1.8 million

Regulatory

ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Nasser Saeed Al Hajri & Partners Contracting (NHS & Partners), a leading construction contractor in the United Arab Emirates. The order is worth approximately USD 1.8 million. The order involves the detailed design, supply and installation of an ISO 8 and ISO 7…